tiprankstipranks
Trending News
More News >
Link-Asia International Medtech Group Ltd. (HK:1143)
:1143
Hong Kong Market
Advertisement

Link-Asia International Medtech Group Ltd. (1143) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Link-Asia International Medtech Group Ltd. has a market cap or net worth of HK$91.96M. The enterprise value is -HK$186.17M.
Market CapHK$91.96M
Enterprise Value-HK$186.17M

Share Statistics

Link-Asia International Medtech Group Ltd. has 224,289,180 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding224,289,180
Owned by Insiders
Owned by Institutions

Financial Efficiency

Link-Asia International Medtech Group Ltd.’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 1.52%.
Return on Equity (ROE)0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)1.52%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee574.03K
Profits Per Employee12.25K
Employee Count835
Asset Turnover0.54
Inventory Turnover7.90

Valuation Ratios

The current PE Ratio of Link-Asia International Medtech Group Ltd. is 13.8. Link-Asia International Medtech Group Ltd.’s PEG ratio is 0.29.
PE Ratio13.8
PS Ratio0.14
PB Ratio0.13
Price to Fair Value0.13
Price to FCF-0.89
Price to Operating Cash Flow-2.16
PEG Ratio0.29

Income Statement

In the last 12 months, Link-Asia International Medtech Group Ltd. had revenue of 479.32M and earned 8.04M in profits. Earnings per share was 0.04.
Revenue479.32M
Gross Profit123.60M
Operating Income15.18M
Pretax Income10.36M
Net Income8.04M
EBITDA4.78M
Earnings Per Share (EPS)0.04

Cash Flow

In the last 12 months, operating cash flow was -43.60M and capital expenditures -4.32M, giving a free cash flow of -47.91M billion.
Operating Cash Flow-43.60M
Free Cash Flow-47.91M
Free Cash Flow per Share-0.21

Dividends & Yields

Link-Asia International Medtech Group Ltd. pays an annual dividend of HK$0.293, resulting in a dividend yield of ―
Dividend Per ShareHK$0.293
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.63
52-Week Price Change-81.28%
50-Day Moving Average0.42
200-Day Moving Average0.35
Relative Strength Index (RSI)46.51
Average Volume (3m)1.05M

Important Dates

Link-Asia International Medtech Group Ltd. upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend DateJun 04, 2015

Financial Position

Link-Asia International Medtech Group Ltd. as a current ratio of 2.66, with Debt / Equity ratio of 17.81%
Current Ratio2.66
Quick Ratio2.51
Debt to Market Cap0.58
Net Debt to EBITDA-47.21
Interest Coverage Ratio3.14

Taxes

In the past 12 months, Link-Asia International Medtech Group Ltd. has paid 3.90M in taxes.
Income Tax3.90M
Effective Tax Rate0.38

Enterprise Valuation

Link-Asia International Medtech Group Ltd. EV to EBITDA ratio is -33.09, with an EV/FCF ratio of 2.09.
EV to Sales-0.33
EV to EBITDA-33.09
EV to Free Cash Flow2.09
EV to Operating Cash Flow2.16

Balance Sheet

Link-Asia International Medtech Group Ltd. has HK$331.35M in cash and marketable securities with HK$94.77M in debt, giving a net cash position of HK$236.58M billion.
Cash & Marketable SecuritiesHK$331.35M
Total DebtHK$94.77M
Net CashHK$236.58M
Net Cash Per ShareHK$1.05
Tangible Book Value Per ShareHK$2.48

Margins

Gross margin is 22.56%, with operating margin of 3.17%, and net profit margin of 1.68%.
Gross Margin22.56%
Operating Margin3.17%
Pretax Margin2.16%
Net Profit Margin1.68%
EBITDA Margin1.00%
EBIT Margin-1.70%

Analyst Forecast

The average price target for Link-Asia International Medtech Group Ltd. is HK$0.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$0.50
Price Target Upside21.95% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-25.16%
EPS Growth Forecast-160.31%

Scores

Smart Score3
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis